Glucagonoma is a rare type of pancreatic tumor that leads to overproduction of glucagon and is associated with symptoms like necrolytic migratory erythema.
First-line treatments include surgery and somatostatin analogs, while radioligand therapy with [177Lu]Lu-DOTA-TATE is used as a second-line option for advanced cases.
This text discusses a unique case of a metastatic glucagonoma successfully treated with [177Lu]Lu-DOTA-TATE when the disease progressed.